Cardlytics Announces Fourth Quarter and Fiscal Year 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Cardlytics (CDLX) Tops Q4 EPS by 11c, Revenues Beat; Offers Q1 Revenue Guidance Below Consensus
March 5, 2019 4:06 PM ESTCardlytics (NASDAQ: CDLX) reported Q4 EPS of ($0.06), $0.11 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $47.8 million versus the consensus estimate of $45.77 million.
Our strong fourth quarter results cap off an exciting and transformational year for Cardlytics, having completed our IPO in February 2018 and solidifying agreements with both the number one and the number three largest banks in the U.S. to launch Cardlytics Direct, said Scott Grimes, CEO & Co-Founder of Cardlytics. We believe our scale, unique capabilities, and ongoing investments in our business will enable us to deliver... More
